
Pill taken by millions on NHS \u2018could also prevent leukaemia\u2019
This gives hope for a potential treatment for those at high risk of developing the disease.
Pill taken by millions on NHS \u2018could also prevent leukaemia\u2019
This gives hope for a potential treatment for those at high risk of developing the disease.
\u2018I stepped on board the Titanic and saw a different side to the sinking'
A VR experience so detailed our reporter could make out wine bottle labels.
British couple killed in cable car crash near Naples are named
One person is seriously injured and another is still missing.
Pill taken by millions on NHS \u2018could also prevent leukaemia\u2019
This gives hope for a potential treatment for those at high risk of developing the disease.
Your surgery could be done by 'innovative' robots just approved for use in NHS
State-of-the-art robotic systems that can help remove tumours or replace a patient’s knee have been approved for use on the NHS.
Health In Tech Announces Appointment of Sanjay Shrestha to Board of Directors
STUART,Fla.,April 11,2025-- Health In Tech (Nasdaq: HIT),an Insurtech platform company backed by third-party AI technology,is pleased to announce the appointment of a new independent director,Sanjay
NEW YORK,April 11,2025--Dany Garcia,Chairwoman & CEO of The Garcia Companies,announces the launch of Danimás,an innovative media company and community built for the modern Trailblazer. Des
DKSH Malaysia Drives Sustainability with Innovative Green Initiatives
DKSH Malaysia is leading the way towards a sustainable future with a series of latest and ongoing initiatives like green logistics,eco-friendly packaging,and renewable energy,highlighting its commitme
LG RECOGNIZED AS 2024 SUPPLIER OF THE YEAR BY GENERAL MOTORS
Company Recognized for Innovation Excellence at GM\'s 33rd Annual Supplier of the Year Award SEOUL,South Korea,April 14,2025-- LG Electronics (LG),a mobility sector technology leader,has been honored
Chromatin Bioscience Signs Collaboration Agreement with Astellas
EDINBURGH,Scotland,April 14,2025-- Chromatin Bioscience,a leader in the design of synthetic promoters and gene control systems,is pleased to announce a collaboration agreement withAstellas Pharma,a g